a

Blade is a smooth and charming, visually stunning and very malleable and flexible

[social_icons type="circle_social" icon="fa-facebook" use_custom_size="yes" custom_size="14" custom_shape_size="17" link="https://www.facebook.com/" target="_blank" icon_margin="0 10px 0 0" icon_color="#ffffff" icon_hover_color="#ffffff" background_color="rgba(255,255,255,0.01)" background_hover_color="#21d279" border_width="2" border_color="#7d7d7d" border_hover_color="#21d279"][social_icons type="circle_social" icon="fa-twitter" use_custom_size="yes" custom_size="14" custom_shape_size="17" link="https://twitter.com/" target="_blank" icon_margin="0 10px 0 0" icon_color="#ffffff" icon_hover_color="#ffffff" background_color="rgba(255,255,255,0.01)" background_hover_color="#21d279" border_width="2" border_color="#7d7d7d" border_hover_color="#21d279"][social_icons type="circle_social" icon="fa-linkedin" use_custom_size="yes" custom_size="14" custom_shape_size="17" link="https://www.linkedin.com/" target="_blank" icon_margin="0 10px 0 0" icon_color="#ffffff" icon_hover_color="#ffffff" background_color="rgba(255,255,255,0.01)" background_hover_color="#21d279" border_width="2" border_color="#7d7d7d" border_hover_color="#21d279"] [vc_empty_space height="31px"] Copyright Qode Interactive 2017

Mislabeled fentanyl patches recalled

Mislabeled fentanyl patches recalled

24 Apr Mislabeled fentanyl patches recalled

Posted at 00:59h in Fentanyl by

Alia Paavola –  | 


is recalling two lots of its transdermal fentanyl patches due to faulty product labeling.

The affected lots of Fentanyl Transdermal System 12 mcg/h transdermal patches were distributed to pharmacies.

Alvogen said a small number of cartons labeled as containing 12 mcg/h patches actually contain 50 mcg/h patches, which are individually labeled as having the 50 mcg/h dose.

3M Drug Delivery Systems manufacturers the product, which helps manage pain in opioid-tolerant patients.

More articles on supply chain:
FDA braces for medical device shortages: 9 things to know
Reports of breast implant ‘illness’ spur FDA safety review
5 supply chain technologies to watch


© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.



[ad_2]

Source link

No Comments

Post A Comment